NanoRepro AG

    Jurisdiction
    Germany
    LEI
    3912008FCA63AGIMEV74
    ISIN
    DE0006577109 (NN6.DE)
    Sectors
    1. Healthcare
    2. Medical - Diagnostics & Research

    Scores

    InsiderPie Expert Score
    50 / 100
    Even with peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Fundamental strength relative to industry (Mohanram G-Value)
    2 / 7

    Profile

    NanoRepro AG develops, manufactures, and distributes rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. Read full profile

    Fundamentals

    Net revenue
    €17.50M
    Gross margin
    23.8%
    EBIT
    -€14.45M
    EBIT margin
    -82.6%
    Net income
    -€9.78M
    Net margin
    -55.9%

    Statement period: - (published )

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    Last dividend amount
    €0.15
    Ex date
    Payment date

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    Jüngst, Lisa Vorstand +5K $1.58 +$7.92K
    Jüngst, Lisa Vorstand +8.5K $1.62 +$13.76K

    Earnings Calls

    Add to watchlist

    Notifications